Perinatal hypoxia causes ventricular enlargement associated with increased atrial natriuretic peptide (ANP) mRNA levels in newborn mice

High Altitude Medicine and Biology

Volumn 4, Issue 2, 2003, Pages 241-254

  Hohimer, A Roger ^a   Mysliwiec, Matt ^a   Lee, Kathryn ^a   Davis, Lowell ^a   Pantely, George A ^a  

^a NONE

Author keywords

Cardiac; Echocardiography; Gender; Hypertrophy; Hypoxic pulmonary vasoconstriction

Indexed keywords

ATRIAL NATRIURETIC FACTOR; ATRIAL NATRIURETIC FACTOR RECEPTOR; MESSENGER RNA;

ADULTHOOD; AMBIENT AIR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EXPOSURE; GENDER; GENE EXPRESSION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART MUSCLE CONTRACTILITY; HEART STRESS; HEART WEIGHT; MOUSE; NEWBORN; NEWBORN HYPOXIA; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; WEIGHT REDUCTION; WILD TYPE;

EID: 0041629237     PISSN: 15270297     EISSN: None     Source Type: Journal    
DOI: 10.1089/152702903322022839     Document Type: Article

References (62)

1. Banchero, N. (1987). Cardiovascular responses to chronic hypoxia [review]. Annu. Rev. Physiol. 49:465-476.
2. Barbera A., Giraud G.D., Reller M.D., Maylie J., Morton M.J., and Thornburg K.L. (2000). Right ventricular systolic pressure load alters myocyte maturation in fetal sheep. Am. J. Physiol. Regul. Integrative Comp. Physiol. 279:R1157-R1164.
3. Barker D.J., and Martyn C.N. (1997). The fetal origins of hypertension [review; 45 refs.]. Adv. Nephrol. Necker Hosp. 26:65-72.
4. Bitar F.F., Feldbaum D.M., Kohman L.J., Litovsky S., and Veit L.J. (1994). Effect of early versus delayed hypoxic environment on neonatal rabbits. J. Surg. Res. 57:264-267.
5. Boluyt M.O., Penney D.G., Clubb F.J. Jr., and White T.P. (1991). Exposure of neonatal rats to carbon monoxide alters cardiac adaptation to aortic constriction. J. Appl. Physiol. 70:2697-2702.
6. Calderone A., Thaik C.M., Takahashi N., Chang D.L.F., and Colucci W.S. (1998). Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts. J. Clin. Invest. 101:812-818.
7. Cameron V.A., Aitken G.D., Ellmers L.J., Kennedy M.A., and Espiner E.A. (1996). The sites of gene expression of atrial, brain, and C-type natriuretic peptides in mouse fetal development: temporal changes in embryos and placenta. Endocrinology 137:817-824.
8. Cao L., and Gardner D.G. (1995). Natriuretic peptides inhibit DNA synthesis in cardiac fibroblasts. Hypertension 25:227-234.
9. Crowe C., Dandekar P., Fox M., Dhingra K., Bennet L., and Hanson M.A. (1995). The effects of anaemia on heart, placenta and body weight, and blood pressure in fetal and neonatal rats. J. Physiol. (Lond.) 488:515-519.
10. de Simone G., Devereux R.B., Kimball T.R., Mureddu G.F., Roman M.J., Contaldo F., and Daniels S.R. (1998). Interaction between body size and cardiac workload: influence on left ventricular mass during body growth and adulthood. Hypertension 31:1077-1082.
11. Douglas P.S., Katz S.E., Weinberg E.O., Chen M.H., Bishop S.P., and Lorell B.H. (1998). Hypertrophic remodeling: gender differences in the early response to left ventricular pressure overload. J. Am. Coll. Cardiol. 32:1118-1125.
12. Fentzke R.C., Korcarz C.E., Shroff S.G., Lin H., Sandelski J., Leiden J.M., and Lang R.M. (1997). Evaluation of ventricular and arterial hemodynamics in anesthetized closed-chest mice. J. Am. Soc. Echocardiogr. 10:915-925.
13. Forman D.E., Cittadini A., Azhar G., Douglas P.S., and Wei J.Y. (1997). Cardiac morphology and function in senescent rats: gender-related differences. J. Am. Coll. Cardiol. 30:1872-1877.
14. Gardner D.G., Deschepper C.F., Ganong W.F., Hane S., Fiddes J., Baxter J.D., and Lewicki J. (1986). Extra-atrial expression of the gene for atrial natriuretic factor. Proc. Natl. Acad. Sci. U.S.A. 83:6697-6701.
15. Green L.R. (2001). Programming of endocrine mechanisms of cardiovascular control and growth. J. Soc. Gynecol. Invest. 8:57-68.
16. Hampl V., and Herget J. (1990). Perinatal hypoxia increases hypoxic pulmonary vasoconstriction in adult rats recovering from chronic exposure to hypoxia. Am. Rev. Respir. Dis. 142:619-624.
17. Hefti M.A., Harder B.A., Eppenberger H.M., and Schaub M.C. (1997). Signaling pathways in cardiac myocyte hypertrophy. J. Mol. Cell Cardiol. 29:2873-2892.
18. Hersey R.M., Nazir M.A., Whitney K.D., Klein R.M., Sale R.D., Hinton D.A., Weisz J., and Gattone V.H. (1989). Atrial natriuretic peptide in heart and specific binding in organs from fetal and newborn rats. Cell Biochem. Funct. 7:35-41.
19. Horio T., Nishikimi T., Yoshihara F., Matsuo H., Takishita S., and Kangawa K. (2000). Inhibitory regulation of hypertrophy by endogenous atrial natriuretic peptide in cultured cardiac myocytes. Hypertension 35:19-24.
20. Hunter C., Barer G.R., Shaw J.W., and Clegg E.J. (1974). Growth of the heart and lungs in hypoxic rodents: a model of human hypoxic disease. Clin. Sci. Mol. Med. 46:375-391.
21. Ito H., Adachi S., Tamamori M., Fujisaki H., Tanaka M., Lin M., Akimoto H., Marumo F., and Hiroe M. (1996). Mild hypoxia induces hypertrophy of cultured neonatal rat cardiomyocytes: a possible endogenous endothelin-1-mediated mechanism. J. Mol. Cell Cardiol. 28:1271-1277.
22. Itoh H., Pratt R.E., and Dzau V.J. (1990). Atrial natriuretic polypeptide inhibits hypertrophy of vascular smooth muscle cells. J. Clin. Invest. 86:1690-1697.
23. Jin H., Chen Y.F., Yang R.H., Jackson R.M., and Oparil S. (1990). Atrial natriuretic peptide clearance receptor agonist lowers pulmonary pressure in hypoxic rats. J. Appl. Physiol. 68:2413-2418.
24. John S.W., Veress A.T., Honrath U., Chong C.K., Peng L., Smithies O., and Sonnenberg H. (1996). Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP. Am. J. Physiol. 271:R109-14.
25. Kishimoto I.I., Rossi K., and Garbers D.L. (2001). A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy. Proc. Natl. Acad. Sci. U.S.A. 98:2703-2706.
26. Klinger J.R., Petit R.D., Curtin L.A., Warburton R.R., Wrenn D.S., Steinhelper M.E., Field L.J., and Hill N.S. (1993). Cardiopulmonary responses to chronic hypoxia in transgenic mice that overexpress ANP. J. Appl. Physiol. 75:198-205.
27. Klinger J.R., Warburton R.R., Pietras L.A., Smithies O., Swift R., and Hill N.S. (1999). Genetic disruption of atrial natriuretic peptide causes pulmonary hypertension in normoxic and hypoxic mice. Am. J. Physiol. 276:L868-L874.
28. Knowles J.W., Esposito G., Mao L., Hagaman J.R., Fox J.E., Smithies O., Rockman H.A., and Maeda N. (2001). Pressure independent enhancement of cardiac hypertrophy in natriuretic receptor A deficient mice. J. Clin. Invest. 107:975-984.
29. Kolar F., Papousek F., Pelouch V., Ostadal B., and Rakusan K. (1998). Pressure overload induced in newborn rats: effects on left ventricular growth, morphology, and function. Pediatr. Res. 43:521-526.
30. Leu M., Ehler E., and Perriard J.C. (2001). Characterisation of postnatal growth of the murine heart. Anat. Embryol. (Berlin) 204:217-224.
31. Lewis A.M., Mathieu-Costello O., McMillan P.J., and Gilbert R.D. (1999). Effects of long-term, high-altitude hypoxia on the capillarity of the ovine fetal heart. Am. J. Physiol 277:H756-H762.
32. Lopez M.J., Wong S.K., Kishimoto I., Dubois S., Mach V., Friesen J., Garbers D.L., and Beuve A. (1995). Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide. Nature 378:65-68.
33. Machida N., Brissie N., Sreenan C., and Bishop S.P. (1997). Inhibition of cardiac myocyte division in c-myc transgenic mice. J. Mol. Cell Cardiol. 29:1895-1902.
34. Martin C., Yu A.Y., Jiang B.H., Davis L., Kimberly D., Hohimer A.R., and Semenza G.L. (1998). Cardiac hypertrophy in chronically anemic fetal sheep: Increased vascularization is associated with increased myocardial expression of vascular endothelial growth factor and hypoxia-inducible factor 1. Am. J. Obstet. Gynecol. 178:527-534.
35. Mayhew T.M., Pharaoh A., Austin A., and Fagan D.G. (1997). Stereological estimates of nuclear number in human ventricular cardiomyocytes before and after birth obtained using physical dissectors. J. Anat. 191:107-115.
36. McKenzie J.C., Kelley K.B., Merisko-Liversidge E.M., Kennedy J., and Klein R.M. (1994). Developmental pattern of ventricular atrial natriuretic peptide (ANP) expression in chronically hypoxic rats as an indicator of the hypertrophic process. J. Mol. Cell Cardiol. 26:753-767.
37. Molkentin J.D., Lu J.R., Antos C.L., Markham B., Richardson J., Robbins J., Grant S.R., and Olson E.N. (1998). A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell 93:215-228.
38. Murotsuki J., Challis J.R., Han V.K., Fraher L.J., and Gagnon R. (1997). Chronic fetal placental embolization and hypoxemia cause hypertension and myocardial hypertrophy in fetal sheep. Am. J. Physiol. 272:R201-R207.
39. Oliver P.M., Fox J.E., Kim R., Rockman H.A., Kim H.S., Reddick R.L., Pandey K.N., Milgram S.L., Smithies O., and Maeda N. (1997). Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A. Proc. Natl. Acad. Sci. U.S.A. 94:14730-14735.
40. Penney D.G., Baylerian M.S., Thill J.E., Fanning C.M., and Yedavally S. (1982). Postnatal carbon monoxide exposure: immediate and lasting effects in the rat. Am. J. Physiol. 243:H328-H339.
41. Penney D.G., Baylerian M.S., Thill J.E., Yedavally S., and Fanning C.M. (1983). Cardiac response of the fetal rat to carbon monoxide exposure. Am. J. Physiol. 244: H289-H297.
42. Penney D.G., Clubb F.J.J., Allen R.C., Jen C., Banerjee S.H., and Hull J.A. (1989). Persistent early heart changes do alter the cardiac response to exercise in adulthood. J. Appl. Cardiol. 4:223-237.
43. Penney D.G., Gargulinski R.B., Hawkins B.J., Santini R., Caldwell-Ayre T.M., and Davidson S.B. (1988). The effects of carbon monoxide on persistent changes in young rat heart: cardiomegaly, tachycardia and altered DNA content. J. Appl. Toxicol. 8:275-283.
44. Penney D.G., Stryker A.E., and Baylerian M.S. (1984). Persistent cardiomegaly induced by carbon monoxide and associated tachycardia. J. Appl. Physiol. 56:1045-1052.
45. Pietschmann M., and Bartels H. (1985). Cellular hyperplasia and hypertrophy, capillary proliferation and myoglobin concentration in the heart of newborn and adult rats at high altitude. Respir. Physiol. 59:347-360.
46. Pinson C.W., Morton M.J., and Thornburg K.L. (1991). Mild pressure loading alters right ventricular function in fetal sheep. Circ. Res. 68:947-957.
47. Poolman R.A., and Brooks G. (1998). Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy. J. Mol. Cell Cardiol. 30:2121-2135.
48. Rockman H.A., Ross R.S., Harris AX, Knowlton K.U., Steinhelper M.E., Field L.J., Ross J.J., and Chien K.R. (1991). Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy [published erratum appears in Proc. Natl. Acad. Sci. U.S.A. 1991 Nov 1; 88(21):9907]. Proc. Natl. Acad. Sci. U.S.A. 88:8277-8281.
49. Rouwet E.V., Tintu AX, Schellings M.W., van Bilsen M., Lutgens E., Hofstra L., Slaaf D.W., Ramsay G., and Le Noble F.A. (2002). Hypoxia induces aortic hypertrophic growth, left ventricular dysfunction, and sympathetic hyperinnervation of peripheral arteries in the chick embryo. Circulation 105:2791-2796.
50. Samson F., Bonnet N., Heimburger M., Rucker-Martin C., Levitsky D.O., Mazmanian G.M., Mercadier J.J., and Serraf A. (2000). Left ventricular alterations in a model of fetal left ventricular overload. Pediatr. Res. 48:43-49.
51. Sartori C., Allemann Y., Trueb L., Delabays A., Nicod P., and Scherrer U. (1999). Augmented vasoreactivity in adult life associated with perinatal vascular insult. Lancet 353:2205-2207.
52. Scott J.N., and Jennes L. (1987). Distribution of atrial natriuretic factor in fetal rat atria and ventricles. Cell Tissue Res. 248:479-481.
53. Silberbach M., Gorenc T., Hershberger R.E., Stork P.J., Steyger P.S., and Roberts C.T., Jr. (1999). Extracellular signal-regulated protein kinase activation is required for the anti-hypertrophic effect of atrial natriuretic factor in neonatal rat ventricular myocytes. J. Biol. Chem. 274:24858-24864.
54. Soonpaa M.H., Kim K.K., Pajak L., Franklin M., and Field L.J. (1996). Cardiomyocyte DNA synthesis and binucleation during murine development. Am. J. Physiol. 271:H2183-H2189.
55. Tanaka N., Ryoke T., Hongo M., Mao L., Rockman H.A., Clark R.G., and Ross J.J. (1998). Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice. Am. J. Physiol. 275:H393-H399.
56. Thompson L.P., Aguan K., Pinkas G., and Weiner C.P. (2000). Chronic hypoxia increases the NO contribution of acetylcholine vasodilation of the fetal guinea pig heart. Am. J. Physiol. Regul. Integrative Comp. Physiol. 279:R1813-R1820.
57. Tucker A., and Penney D.G. (1993). Pulmonary vascular responsiveness in rats following neonatal exposure to high altitude or carbon monoxide. Exp. Lung Res. 19:699-713.
58. Vasan R.S., Larson M.G., Benjamin E.J., Evans J.C., and Levy D. (1997). Left ventricular dilatation and the risk of congestive heart failure in people without myocardial infarction [see comments]. N. Engl. J. Med. 336:1350-1355.
59. Vijayakumar M., Fall C.H., Osmond C., and Barker D.J. (1995). Birth weight, weight at one year, and left ventricular mass in adult life. Br. Heart J. 73:363-367.
60. Vikstrom K.L., Bohlmeyer T., Factor S.M., and Leinwand L.A. (1998). Hypertrophy, pathology, and molecular markers of cardiac pathogenesis. Circ. Res. 82:773-778.
61. Wu C.F., Bishopric N.H., and Pratt R.E. (1997). Atrial natriuretic peptide induces apoptosis in neonatal rat cardiac myocytes. J. Biol. Chem. 272:14860-14866.
62. Yoshimine K., Horiuchi M., Suzuki S., Kobayashi K., Abdul J.M., Masuda M., Tomomura M., Ogawa Y., Itoh H., Nakao K., Osame M., and Saheki T. (1997). Altered expression of atrial natriuretic peptide and contractile protein genes in hypertrophied ventricle of JVS mice with systemic carnitine deficiency. J. Mol. Cell Cardiol. 29:571-578.